Mark Kloos

1.1k total citations
14 papers, 736 citations indexed

About

Mark Kloos is a scholar working on Hematology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Kloos has authored 14 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Kloos's work include Platelet Disorders and Treatments (8 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Hereditary Neurological Disorders (3 papers). Mark Kloos is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Hereditary Neurological Disorders (3 papers). Mark Kloos collaborates with scholars based in United States, Denmark and United Kingdom. Mark Kloos's co-authors include Margaret A. Pericak‐Vance, Douglas A. Marchuk, Ingrid K. Svenson, P. C. Gaskell, Allison E. Ashley‐Koch, David C. Rubinsztein, Andrew Dearlove, Evan Reid, Felicia L. Graham and L.A. Hughes and has published in prestigious journals such as Nature Genetics, Blood and The American Journal of Human Genetics.

In The Last Decade

Mark Kloos

14 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kloos United States 8 304 283 181 176 143 14 736
Kumi Sakoe Japan 20 846 2.8× 461 1.6× 202 1.1× 85 0.5× 44 0.3× 33 1.1k
Jonathan Mandelbaum United States 6 351 1.2× 102 0.4× 140 0.8× 64 0.4× 69 0.5× 7 753
Catherine Dubreuil United States 9 365 1.2× 458 1.6× 38 0.2× 81 0.5× 33 0.2× 10 793
Seyedmehdi Shojaee United States 7 240 0.8× 68 0.2× 104 0.6× 47 0.3× 28 0.2× 13 508
Nora P. Dooley Canada 12 449 1.5× 91 0.3× 127 0.7× 92 0.5× 73 0.5× 14 1.1k
Alessandra Musso Italy 14 178 0.6× 74 0.3× 72 0.4× 46 0.3× 67 0.5× 16 665
Usha R. Reddy United States 14 431 1.4× 349 1.2× 45 0.2× 54 0.3× 53 0.4× 22 702
Hana S. Suidan Switzerland 15 516 1.7× 278 1.0× 44 0.2× 133 0.8× 155 1.1× 19 1.0k
Isabelle Cornez Germany 10 501 1.6× 183 0.6× 24 0.1× 156 0.9× 165 1.2× 12 904
Tada-aki Hori Japan 8 440 1.4× 395 1.4× 51 0.3× 30 0.2× 84 0.6× 8 1.0k

Countries citing papers authored by Mark Kloos

Since Specialization
Citations

This map shows the geographic impact of Mark Kloos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kloos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kloos more than expected).

Fields of papers citing papers by Mark Kloos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kloos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kloos. The network helps show where Mark Kloos may publish in the future.

Co-authorship network of co-authors of Mark Kloos

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kloos. A scholar is included among the top collaborators of Mark Kloos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kloos. Mark Kloos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lozier, Jay N., Mark Kloos, Elizabeth P. Merricks, et al.. (2016). Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII.. PubMed. 66(5). 405–411. 4 indexed citations
2.
3.
Novelli, Enrico M., et al.. (2012). Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A. Thrombosis and Haemostasis. 109(2). 248–254. 18 indexed citations
4.
Jankowitz, Rachel C., et al.. (2011). Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia. Thrombosis and Haemostasis. 106(10). 641–645. 16 indexed citations
5.
Nichols, Timothy C., Dwight A. Bellinger, Elizabeth P. Merricks, et al.. (2010). Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies. PubMed. 2010. 1–11. 22 indexed citations
6.
Ragni, Margaret V., Rachel C. Jankowitz, Elizabeth P. Merricks, et al.. (2008). A phase II prospective open‐label escalating dose trial of recombinant interleukin‐11 in mild von Willebrand disease. Haemophilia. 14(5). 968–977. 25 indexed citations
7.
Jankowitz, Rachel C., Margaret V. Ragni, Elizabeth P. Merricks, et al.. (2008). Recombinant Interleukin-11 (rhIL-11) in Women with Refractory Menorrhagia and Von Willebrand Disease.. Blood. 112(11). 1210–1210. 2 indexed citations
8.
Jankowitz, Rachel C., Elizabeth P. Merricks, Mark Kloos, et al.. (2007). RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD. Journal of Thrombosis and Haemostasis. 5. O–T. 1 indexed citations
9.
Ezban, Mirella, Dorthe Viuff, Judi Møss, et al.. (2007). Single Dose Administration of rFVIIa and NN1731 in Two Hemophilia A Dogs.. Blood. 110(11). 3144–3144. 1 indexed citations
10.
Merricks, Elizabeth P., et al.. (2006). Recombinant Human IL-11 (rhIL-11, Neumega®) Increases VWF Activity in Type 1 Von Willebrand Disease.. Blood. 108(11). 1003–1003. 1 indexed citations
11.
Svenson, Ingrid K., Mark Kloos, Carol J. Gallione, et al.. (2005). Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia. Neurogenetics. 6(3). 135–141. 14 indexed citations
12.
Svenson, Ingrid K., Mark Kloos, P. C. Gaskell, et al.. (2004). Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics. 5(3). 157–164. 61 indexed citations
13.
Huang, Erich, Seiichi Ishida, Jennifer Pittman, et al.. (2003). Gene expression phenotypic models that predict the activity of oncogenic pathways. Nature Genetics. 34(2). 226–230. 189 indexed citations
14.
Reid, Evan, Mark Kloos, Allison E. Ashley‐Koch, et al.. (2002). A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10). The American Journal of Human Genetics. 71(5). 1189–1194. 377 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kumi Sakoe Breakdown of academic impact, for papers by Jonathan Mandelbaum Breakdown of academic impact, for papers by Catherine Dubreuil Breakdown of academic impact, for papers by Seyedmehdi Shojaee Breakdown of academic impact, for papers by Nora P. Dooley Breakdown of academic impact, for papers by Alessandra Musso Breakdown of academic impact, for papers by Usha R. Reddy Breakdown of academic impact, for papers by Hana S. Suidan Breakdown of academic impact, for papers by Isabelle Cornez Breakdown of academic impact, for papers by Tada-aki Hori
Rankless by CCL
2026